Prospects for the Development of a Dengue Vaccine
Journal Title: Journal of Vaccines and Immunology - Year 2016, Vol 2, Issue 1
Abstract
Dengue is a mosquito-borne viral disease which is currently an important and rapid growing health problem across the globe. Four closely related dengue serotypes cause the disease, which ranges from asymptomatic infection to undifferentiated fever, dengue fever (DF), and dengue hemorrhagic fever (DHF). Specific antiviral medications are not available for dengue and successful treatment, which is mainly supportive, depends on early recognition of the disease and careful monitoring for shock. Prevention of dengue depends on the control of the mosquito vector which has had only limited success. Development of a dengue vaccine is seen as a new tool to prevent this potentially fatal disease. The scope and intensity of dengue vaccine development has increased dramatically in the last decade. A live-attenuated tetravalent dengue vaccine based on chimeric yellow fever dengue virus, has progressed to licensure in several dengue endemic countries in 2015 after its phase III efficacy study involving more than 30,000 volunteers from Asia and Latin America. Several other dengue vaccine candidates are currently being evaluated in clinical and preclinical studies included other live attenuated vaccines, subunit, DNA purified inactivated vaccine candidates as well as virus-vectored and virus-like particle-based vaccines. Since dengue poses a heavy economic cost to the health system and society, the potential economic benefits are associated with promising dengue prevention interventions such as dengue vaccine and vector control innovations.
Authors and Affiliations
Thisyakorn Usa
Keywords
Related Articles
- EP ID EP553748
- DOI 10.17352/jvi.000015
- Views 61
- Downloads 0
Measuring autophagy level along with vaccine reactive IFN-γ+CD4+ Th1 cells may be a promising approach to understand efficacy of anti TB vaccine(s)
Autophagy is a homeostatic process in the eukaryotic cells which contributes towards degradation of unwanted cellular constituents, killing of the invading intracellular microbes and generation of cell mediated immunity...
Pathogenicity of Duck-Originated H9N2 Influenza Viruses on Chickens
Background: The spreading of H9N2 avian influenza viruses in poultry in Eurasia and Africa accompanied with the great economic losses to poultry industry in past decades has attracted the great attention of whole world....
Nanoparticles Vaccines Now and Future!
While the advanced use of effective vaccines has had an extraordinary impact on global health, there remain many diseases for which vaccines are not available. The concept of therapeutic infection vaccines is based on th...
Liposome Adjuvants: Simultaneous Induction of Innate and Adaptive Immunity is Key to Success
The current generation vaccines are mainly composed of highly purified antigens and tend to be poorly immunogenic, requiring potent adjuvants for their success. The adjuvants currently available suffer from various drawb...
Immunity against Pasteurella multocida in Animals Vaccinated with Inactivated Pasteurella multocida and Herbal Adjuvant ‘DIP-HIP’
Background: Haemorrhagic septicaemia (HS) is acute, highly contagious form of disease of water buffalo, cattle, and bison caused by Pasteurella multocida (PM). It is considered the most economically important bacterial d...